Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
TissueTech history
TissueTech company history timeline
2003 Company received FDA 510K Clearance for PROKERA®: First amniotic allograft for use without sutures ShareShareTweetPin
Prior to joining Ballast Point Ventures in 2004, Matt Rice began his career in the Health Care Investment Banking Group of Raymond James Financial, where he focused primarily on the specialty pharmaceutical, drug distribution, and contract research organization sectors.
Matt also worked in the Strategic Alliances group at the Novartis Institutes for BioMedical Research prior to rejoining Ballast Point Ventures as a Vice President in 2008.
2010 Company launches AmnioGuard®: first umbilical cord allograft for clinical use ShareShareTweetPin
In 2011, a second commercial entity, Amniox Medical, Inc. was founded to market the company’s proprietary technology in the orthopedic, wound care, and spine markets.
Prior to joining EW in 2013, Mr.
2015: recipient of the prestigious Tibbetts Award from the United States Small Business Administration (SBA)
2017: received the award for Spine Technology Innovation in Biologics at the North American Spine Society annual meeting
White joined EW Healthcare in May 2019 as Operating Partner.
In 2022, TissueTech has unveiled a corporate rebranding, including a name change and a new logo.
Rate how well TissueTech lives up to its initial vision.
TissueTech jobs
Do you work at TissueTech?
Is TissueTech's vision a big part of strategic planning?
TissueTech history FAQs
Zippia gives an in-depth look into the details of TissueTech, including salaries, political affiliations, employee data, and more, in order to inform job seekers about TissueTech. The employee data is based on information from people who have self-reported their past or current employments at TissueTech. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by TissueTech. The data presented on this page does not represent the view of TissueTech and its employees or that of Zippia.
TissueTech may also be known as or be related to TISSUETECH INC, TISSUETECH, INC., TissueTech, TissueTech Inc, TissueTech, Inc. and Tissuetech, Inc.